The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

LGP by the numbers
More From The Market Online
The Market Online Video

ASX Market Close: Banks lead Index to finish the week on a high | September 6, 2024

The bank stocks rallied leading the index higher, but Energy and mining stocks slumped in the…
  • Sean Boss
  • 2 mins
  • 06 September 2024 18:01 (AEST)
IPO concept

Is the ASX getting its groove back? Here’s 5 IPOs in September to watch

After another slow year for IPOs on the ASX, September is looking like it could be…
Money is tight concept 2

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

At the start of this week we saw NVIDIA – as a proxy for the AI…
The Market Online Video

ASX Market Update: CBA breaks record as banks lead Index higher | September 6, 2024

Bank stocks have surged and dragged the market higher with the big 4 all outperforming and…